Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$13.27 - $25.5 $69,004 - $132,600
5,200 New
5,200 $93,000
Q4 2021

Jan 24, 2022

SELL
$27.59 - $66.39 $110,360 - $265,560
-4,000 Closed
0 $0
Q2 2021

Jul 26, 2021

SELL
$57.98 - $96.6 $63,778 - $106,260
-1,100 Reduced 21.57%
4,000 $332,000
Q3 2020

Dec 14, 2020

BUY
$43.0 - $84.01 $163,400 - $319,238
3,800 Added 292.31%
5,100 $376,000
Q4 2019

Jan 24, 2020

BUY
$17.25 - $49.51 $22,425 - $64,363
1,300 New
1,300 $49,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $189M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.